March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Mucosal Addressin Cell Adhesion Molecule (MAdCAM)-1 Plays a Pivotal Role in Dendritic Cell Recruitment to the Cornea During Inflammation
Author Affiliations & Notes
  • Aslihan Turhan
    Cornea, Massachusetts Eye and Ear Infirmary, West Roxbury, Massachusetts
  • Takefumi Yamaguchi
    Cornea, Massachusetts Eye and Ear Infirmary, West Roxbury, Massachusetts
  • Ulrich H. von Andrian
    Cornea, Massachusetts Eye and Ear Infirmary, West Roxbury, Massachusetts
  • Pedram Hamrah
    Cornea, Massachusetts Eye and Ear Infirmary, West Roxbury, Massachusetts
  • Footnotes
    Commercial Relationships  Aslihan Turhan, None; Takefumi Yamaguchi, None; Ulrich H. von Andrian, None; Pedram Hamrah, None
  • Footnotes
    Support  NIH K08-EY020575, Fight for Sight, Falk Medical Research Trust, Research to Prevent Blindness Career Development Award
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3140. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aslihan Turhan, Takefumi Yamaguchi, Ulrich H. von Andrian, Pedram Hamrah; Mucosal Addressin Cell Adhesion Molecule (MAdCAM)-1 Plays a Pivotal Role in Dendritic Cell Recruitment to the Cornea During Inflammation. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3140.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The cornea is endowed with resident dendritic cells (DC). We have recently shown that vascular cell adhesion molecule (VCAM)-1 and P-selectin mediate, in part, DC recruitment to the cornea. This study aims to analyze the role of MAdCAM-1, a molecule previously not described on the ocular surface, on DC homing to cornea.

Methods: : Rolling and adhesion of adoptively transferred fluorescently-labeled DC were studied in limbal vessels of BALB/c mice by intravital microscopy (IVM, 500 Mikron Instruments) in steady state and suture-induced inflammation in vivo. Anti-MAdCAM-1 blocking antibody or controls antibody were injected intravenously (i.v.) 30 minutes before IVM recordings. Separately, DC were treated with blocking antibodies to MAdCAM-1 ligands α4β7 or L-Selectin prior to injection. Homing (recruitment) of DC to normal or inflamed corneas were studied by ex vivo confocal microscopy (Olympus Fluoview 1000) 24 hours after i.v. injection of fluorescently-labeled DC. Flow cytometry studies were performed on DC, purified by magnetic cell separation and analysed for DC markers and MAdCAM-1 ligands.

Results: : Blockade of MAdCAM-1 or L-selectin did not affect DC rolling or adhesion during steady state compared to controls (p=0.23). However, MAdCAM-1 significantly reduced the rolling fraction in inflamed corneas (4.1 %) as compared to controls (20.7%; p< 0.001). Further, anti-MAdCAM-1 treatment profoundly reduced the sticking efficiency of DC during inflammation (0.4%) compared to controls (3.4%; p< 0.001).Homing experiments with blockade of anti-MAdCAM-1 (18.4 cells/mm2; p=0.005) or its ligand α4β7 (4.5 cells/mm2; p=0.003), α4 (12.1 cells/mm2, p=0.032) and β7 (3.2 cells/mm2, p=0.007), showed significant reduction of DC homing to the inflamed cornea as compared to controls (51.5 cells/mm2). Flow cytometry confirmed expression of both α4β7 and L-selectin on CD11c-high DC.

Conclusions: : We demonstrate, for the first time, a role of MAdCAM-1 in leukocyte recruitment to the cornea through limbal vessels. MAdCAM-1 mediates rolling and sticking of DC during inflammation, but not in steady state. MAdCAM-1 or its ligands may provide new molecular targets for pharmacological intervention in inflammatory, infectious, alloimmune and autoimmune corneal diseases.

Keywords: cornea: basic science • immunomodulation/immunoregulation • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×